Article Top Ad
Reading Time: 2 minutes

Villers-lès-Nancy, 7 June 2019 – 8:00 a.m. (CET)

PRESS RELEASE

ANNUAL ORDINARY GENERAL MEETING
ON JUNE, 27, 2019

On-line Availability of Meeting Materials

The shareholders of PHARMAGEST INTERACTIVE are invited to attend the Annual Ordinary General Meeting that will be held on Thursday June 27, 2019 at 5.00 pm, at the Restaurant Le Clos Jeannon located in VILLERS-LES-NANCY (54600), 2-6 bis Rue Saint Fiacre.

The Preliminary Notice of Meeting, including the agenda, the draft resolutions the Board of Directors submits to the vote of the shareholders, as well as information concerning the Shareholders’ Meeting attendance and voting procedures, was published in the BALO (Bulletin des Annonces Légales et Obligatoires) of May 20, 2019.

Pursuant to article R. 225-73-1 of the French commercial code, the Meeting Materials as well as the form of proxy are available on the company’s web site: www.pharmagest.com, Finance, since June 6, 2019.

A convening notice to attend the meeting will be published on June 10, 2019 in the BALO, in the Official Journal “Tablettes Lorraines” and on the company’s website www.pharmagest.com.

About Pharmagest Group:

Pharmagest Group is the French pharmacy information technology leader, with a market share of more than 44% and more than 1,000 employees. The Group’s strategy is based on a core business of improving healthcare through information technology innovation and developing two priority areas: 1/ services and technologies for healthcare professionals, with a focus on assisting pharmacies in patient medication compliance; and 2/ technologies for improving the efficacy of healthcare systems.

To roll out this strategy, Pharmagest Group has developed specialised businesses, including pharmacy IT, e-Health solutions, solutions for healthcare professionals, solutions for pharmaceutical laboratories, connected health devices and apps, and a sales financing marketplace…

These businesses are divided into four Divisions: Pharmacy – Europe Solutions; Health and Social Care Facilities Solutions; e-Health Solutions and Fintech.

Listed on Euronext Paris™ – Compartment B
Indices: CAC® SMALL and CAC® All-Tradable par inclusion
Eligible for the Long-Only Deferred Settlement Service (SRD)
ISIN: FR 0012882389 – Reuters: PHA.PA – Bloomberg: – PMGI FP

For all the latest news go to www.pharmagest.com

Follow Pharmagest on Twitter: @Pharmagest, Linkedin and Facebook

CONTACTS

Analyst and Investor Relations:
Chief Administrative and Financial Officer: Jean-Yves SAMSON
Tel. +33 (0)3 83 15 90 67 – [email protected]

Financial Communications and Media Relations:
FIN’EXTENSO – Isabelle APRILE

Tel. +33 (0)1 39 97 61 22 – [email protected]

Attachment